$DMIIU
Drugs Made In America Acquisition II Corp.
Nasdaq · Blank Checks · New York, NY
DMIIU chart
What traders are saying about $DMIIU
Latest postsDrugs Made In America Acquisition II Corp. news
- Drugs Made In America Acquisition II Corp. Estimates – NASDAQ:DMIIU
TradingView ·
- NexGen Energy’s Rook I Project Emerges as a Key Source in the Next Uranium Supply Wave
fool.com ·
- Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company
Yahoo Finance ·
Drugs Made In America Acquisition II Corp. key financials
| USD | 2025 | 2024 |
|---|---|---|
| Net income | $4.2M | – |
| Total assets (year end) | $505.0M | $138,064 |
| Cash and equivalents (year end) | $223 | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Drugs Made In America Acquisition II Corp.
- Ticker
- DMIIU (Nasdaq)
- Industry
- Blank Checks
- Headquarters
- New York, NY
- Fiscal year end
- December 31
- SEC CIK
- 2040475
Frequently asked questions
What exchange is Drugs Made In America Acquisition II Corp. listed on?
Drugs Made In America Acquisition II Corp. trades on the Nasdaq under the ticker symbol DMIIU.
What industry is Drugs Made In America Acquisition II Corp. in?
Drugs Made In America Acquisition II Corp. is classified by the SEC under "Blank Checks".
Where is Drugs Made In America Acquisition II Corp. headquartered?
Drugs Made In America Acquisition II Corp.'s business address on file with the SEC is in New York, NY.
When does Drugs Made In America Acquisition II Corp.'s fiscal year end?
Drugs Made In America Acquisition II Corp.'s fiscal year ends on December 31.